The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance

Adán Arizmendi-Izazaga,Ricardo Martínez-Baltazar,Amarilis Liborio-Bautista,Monserrat Olea-Flores,Julio Ortiz-Ortiz,Napoleón Navarro-Tito

DOI: https://doi.org/10.1016/j.biochi.2022.10.012

IF: 4.372

Biochimie

Abstract:The RE-1 silencing transcription factor (REST), or neuron restrictive silencing factor (NRSF), was first identified as a repressor of neuronal genes in non-neuronal tissue. Interestingly, this transcription factor may act as a tumor suppressor or an oncogenic role in developing neuroendocrine and other tumors in patients. The hallmarks of cancer include six biological processes, including proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, inducing angiogenesis, and activating invasion and metastasis. In addition to two emerging hallmarks, the reprogramming of energy metabolism and evasion of the immune response are all implicated in the development of human tumors. It is essential to know the role of these processes as they will affect the outcome of alternatives for cancer treatment. Various studies in this review demonstrate that NRSF/REST affects the different hallmarks of cancer that could position NRSF/REST as an essential target in the therapy and diagnosis of certain types of cancer.